Keratoconus Treatment Market in-depth, Detailed Survey and Outlook Report Shows How Top Companies Is Able to Survive in Future Till 2030
Increasing Demand in North America, Europe to Drive Keratoconus
Treatment Market
The Keratoconus
Treatment Market was valued at USD 358.55 million in 2019 and is expected
to register a CAGR of 4.72% during the forecast period of 2020 to 2027. Keratoconus
is a progressive eye condition in which the cornea, usually round and small,
appears cone-like. Keratoconus frequently has to do with light overexposure,
constant eye rubbing, improperly fitting contact lenses and chronic eye
irritation. Keratoconus care depends on the seriousness of the disease and how
easily the condition progresses.
List of Key Companies Covered
in this report:
Global Keratoconus Treatment Market Players are
HOYA Vision Care Company
(Japan) 2. Menicon Co., Ltd. (Japan) 3. Cooper Companies, Inc. (US) 4. Bausch
Health (Canada) 5. SynergEyes (US) 6. Carl Zeiss Meditec AG (Germany) 7.
Contamac (UK) 8. SEED Co., Ltd (Japan) 9. Novartis AG (Switzerland) 10. Johnson
& Johnson Services, Inc. (US)
Segmentation:
The global keratoconus treatment
market is segmented on the basis of type, diagnosis, treatment, end use, and
region.
·
By type, the global keratoconus treatment
market is segmented into forme fruste keratoconus, corneal hydrops,
keratoglobus, pellucid marginal degeneration, posterior keratoconus, and
others.
·
By diagnosis, the market is segmented
into computerized corneal mapping, keratometry, slit-lamp examination,
refraction test, and others. Slit-lamp examination includes tonometry, vision
testing, and others.
·
On the basis of treatment, the market has
been segmented into lenses, surgery, collagen cross-linking, and others. The
lenses segment is sub-segmented into eyeglasses or soft contact lenses, hard
contact lenses, piggyback lenses, hybrid lenses, scleral lenses, and others.
Surgery is sub-segmented into corneal inserts, cornea transplant, and others.
The collagen cross-linking process is still in development; more research is
required to implement this treatment option on a commercial scale.
·
By end use, the global keratoconus
treatment market is segmented into eye hospitals and clinics, medical research
centers, academic institutes, and others. Eye hospitals and clinics held the
majority share in the global keratoconus treatment market in 2016 and are
likely to remain the leading revenue generator in the coming years.
Regional Analysis:
The Americas are likely to remain
the highest grossing regional market for the global keratoconus treatment
market over the forecast period. North America is likely to dominate the global
market in the coming years due to the increasing demand for advanced,
progressive keratoconus treatments in the region’s highly advanced healthcare
sector. The increasing demand for more progressive lenses and other vision
correction devices is likely to remain the major driver for the North America
market for keratoconus treatment over the forecast period. Increasing awareness
about ophthalmic conditions in North America is likely to result in steady
growth of the keratoconus treatment market in North America over the forecast
period.
Europe is the second largest
regional market for the global keratoconus treatment market and is likely to
hold a significant share in the global market’s revenue in the coming years.
The presence of strong healthcare research infrastructure in North America and
Europe is likely to be the major driver for the keratoconus treatment market
over the forecast period. From diagnosis to treatment, the keratoconus
treatment market is in a stage of highly progressive evolution, with new
treatments and diagnostic devices and techniques being discovered every year.
The strong presence of research channels into optics and glassmaking in Europe
is likely to remain a major driver for the Europe keratoconus treatment market
over the forecast period. Optics and glassmaking has a proud and longstanding
tradition in Europe, with European glassmaking going back centuries, being the
birthplace of glass as a commercially viable, producible material. This has led
to contact lens making being a highly viable industry in Europe. This is likely
to remain a major driver for the Europe keratoconus treatment market over the
forecast period.
Asia Pacific is likely to exhibit
rapid growth in the global keratoconus treatment market over the forecast
period due to the growing awareness about ophthalmic conditions such as
keratoconus, the increasing government support for research into the healthcare
sector and medical devices, and the increasing availability of advanced
treatments for keratoconus. Increasing availability of advanced diagnostic
channels for keratoconus is likely to be a major driver for the keratoconus
treatment market in Asia Pacific over the forecast period.
Industry New:
·
In August 2019, a new device was developed for
preclinical stage keratoconus diagnosis. The device uses polarimetric
interferometry to detect preclinical stage changes related to keratoconus,
providing the chance to tackle the disease head on before it develops. The most
viable options for keratoconus treatment at present are centered on damage
control, making this development important for the keratoconus treatment
market.
Related Report-
https://theomnibuzz.com/endoprosthesis-market-information-figures-and-analytical-insights-2022-2030/ |
About US:
Market Research Future (MRFR) enable customers to unravel the
complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment